MaaT Pharma S.A.
MAAT.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €0 | €0 | €0 | €0 |
| - Cash | €0 | €0 | €0 | €0 |
| + Debt | €0 | €0 | €0 | €0 |
| Enterprise Value | €0 | €0 | €0 | -€0 |
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | 44.3% | 55.8% | 47.1% | – |
| Gross Profit | €0 | €0 | €0 | €0 |
| % Margin | 61.1% | 35.2% | 76.3% | 82.9% |
| EBITDA | -€0 | -€0 | -€0 | -€0 |
| % Margin | -819.2% | -990.4% | -916% | -881.7% |
| Net Income | -€0 | -€0 | -€0 | -€0 |
| % Margin | -898.8% | -885% | -959% | -927.9% |
| EPS Diluted | -2.2 | -1.73 | -1.39 | -3.72 |
| % Growth | -27.2% | -24.5% | 62.6% | – |
| Operating Cash Flow | -€0 | -€0 | -€0 | -€0 |
| Capital Expenditures | -€0 | -€0 | -€0 | -€0 |
| Free Cash Flow | -€0 | -€0 | -€0 | -€0 |